Tocqueville Asset Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,125
| Closed | -$17K | – | 636 |
|
|
2022
Q3 | $17K | Sell |
2,125
-550
| -21% | -$4.4K | ﹤0.01% | 593 |
|
|
2022
Q2 | $56K | Hold |
2,675
| – | – | ﹤0.01% | 654 |
|
|
2022
Q1 | $101K | Hold |
2,675
| – | – | ﹤0.01% | 692 |
|
|
2021
Q4 | $150K | Sell |
2,675
-1,025
| -28% | -$57.5K | ﹤0.01% | 720 |
|
|
2021
Q3 | $267K | Buy |
3,700
+2,260
| +157% | +$163K | ﹤0.01% | 651 |
|
|
2021
Q2 | $138K | Sell |
1,440
-888
| -38% | -$85.1K | ﹤0.01% | 721 |
|
|
2021
Q1 | $344K | Sell |
2,328
-275
| -11% | -$40.6K | 0.01% | 615 |
|
|
2020
Q4 | $364K | Buy |
2,603
+1,585
| +156% | +$222K | 0.01% | 591 |
|
|
2020
Q3 | $154K | Buy |
+1,018
| New | +$154K | ﹤0.01% | 634 |
|